Share
Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis (in English)
Lu, Pu-Xuan ; Lu, Hong-Zhou ; Yi, Yong-Xiang (Author)
·
Springer
· Hardcover
Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis (in English) - Lu, Pu-Xuan ; Lu, Hong-Zhou ; Yi, Yong-Xiang
$ 161.04
$ 169.99
You save: $ 8.95
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Tuesday, July 09 and
Wednesday, July 10.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis (in English)"
Tuberculosis is among the top 10 causes of death worldwide.The WHO clearly proposed that drug-resistant tuberculosis is one of the three major challenge in tuberculosis prevention and control .The book consists of detection of drug-resistant TB and its epidemics, laboratory examination for drug-resistant tubercle bacillus, pathogenic mechanism of drug-resistant TB and its diagnosis, differential diagnosis, treatment, prevention and prognosis of drug-resistant pulmonary TB. This book also focuses on the information of classic cases of drug-resistant TB, including mono-drug-resistant (including Rifampicin resistance, etc.), multidrug-resistant, poly-drug-resistant, extensive-drug-resistant (pre-extensive-drug-resistant), drug-resistant bronchial TB, and pediatric drug-resistant, as well as AIDS complicated with drug-resistant TB, and diagnosis and treatment of drug-resistant cervical TB lymphadenitis. The book also provided a comprehensive description and in-depth analysis for each selected case and a systematic explanation for latest cutting-edge issues, such as dynamic changes in images during the treatment of drug-resistant TB as well as the research and application of artificial intelligence in diagnosing drug-resistant TB, to further inspire our readers. This is a useful book to refer to for respiratory physicians, radiologists, and clinicians in preventive medicine, as well as government officials working in health policies.
